IRIS
ARBITRIO, Mariamena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 873
AS - Asia 808
EU - Europa 663
SA - Sud America 152
AF - Africa 39
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 2.546
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 828
IT - Italia 344
SG - Singapore 319
BR - Brasile 116
CN - Cina 115
IN - India 103
DE - Germania 87
GB - Regno Unito 76
VN - Vietnam 73
HK - Hong Kong 37
FI - Finlandia 36
CA - Canada 29
SE - Svezia 24
ID - Indonesia 23
PK - Pakistan 23
JO - Giordania 22
NL - Olanda 19
BD - Bangladesh 14
ES - Italia 12
RU - Federazione Russa 12
MX - Messico 11
FR - Francia 10
TR - Turchia 10
ZA - Sudafrica 10
CO - Colombia 9
EG - Egitto 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 7
EC - Ecuador 7
IQ - Iraq 7
LT - Lituania 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AR - Argentina 6
JP - Giappone 6
NG - Nigeria 6
PE - Perù 6
AU - Australia 5
ET - Etiopia 5
IE - Irlanda 5
IR - Iran 5
KR - Corea 5
LB - Libano 5
CY - Cipro 4
EU - Europa 4
KE - Kenya 4
MA - Marocco 4
MY - Malesia 4
BG - Bulgaria 3
PH - Filippine 3
RO - Romania 3
UA - Ucraina 3
UZ - Uzbekistan 3
CH - Svizzera 2
CL - Cile 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
LK - Sri Lanka 2
PL - Polonia 2
PS - Palestinian Territory 2
PY - Paraguay 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BO - Bolivia 1
GE - Georgia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 2.546
Salva come PNG Salva come JPEG
Città #
Singapore 165
Chandler 124
Ashburn 78
Dallas 63
Munich 62
Santa Clara 50
Chicago 48
Bengaluru 46
Hefei 45
London 40
Ho Chi Minh City 33
Milan 27
Hong Kong 26
Turku 25
Lawrence 24
Princeton 24
Catanzaro 22
Beijing 20
Naples 19
Amman 14
Los Angeles 13
The Dalles 13
Boardman 12
Carbonia 12
Helsinki 11
New York 11
São Paulo 11
Hanoi 10
Ottawa 10
Parma 10
San Nicola Manfredi 10
Spezzano della Sila 10
Wilmington 10
Rome 9
Delhi 8
Irbid 8
Brooklyn 7
Frankfurt am Main 7
Kaunas 7
Madrid 7
San Francisco 7
Santo Stefano di Rogliano 7
Chennai 6
Cosenza 6
Da Nang 6
Ercolano 6
Montreal 6
Seattle 6
Stockholm 6
Afragola 5
Atlanta 5
Cardiff 5
Des Moines 5
Dhaka 5
Hyderabad 5
Lucknow 5
Olomouc 5
Pune 5
Redmond 5
Riyadh 5
Sacramento 5
Addis Ababa 4
Ankara 4
Brescia 4
Florianópolis 4
Islamabad 4
Jeddah 4
Johannesburg 4
Kuala Lumpur 4
Lahore 4
Nairobi 4
Nicosia 4
Redwood City 4
Richmond 4
Thái Bình 4
Tokyo 4
Tubarão 4
West Jordan 4
Acquaviva delle Fonti 3
Ajman 3
Banyumas 3
Berlin 3
Biên Hòa 3
Bologna 3
Bristol 3
Carapicuíba 3
Castrovillari 3
Catania 3
Charlotte 3
Chía 3
Dubai 3
Faisalabad 3
Grottaglie 3
Haiphong 3
Istanbul 3
Lima 3
Melito di Porto Salvo 3
Mileto 3
Noida 3
Norwalk 3
Totale 1.401
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 406
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 118
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 96
miR-22 suppresses DNA ligase III addiction in multiple myeloma 96
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 79
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 67
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 65
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 62
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 61
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 60
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling 58
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 58
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 57
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 56
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 56
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 53
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 53
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 52
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 52
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 51
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 50
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 48
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 48
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 47
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 45
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 45
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 44
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 44
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis 43
Mmrf-commpass data integration and analysis for identifying prognostic markers 43
Integration of DNA Microarray with Clinical and Genomic Data 43
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 40
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 39
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 38
Ethical Perspectives on Pharmacogenomic Profiling 37
Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson’s disease 37
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity 36
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 36
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 35
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity 34
Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS 33
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 31
null 31
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 30
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 24
Polymorphisms and Pharmacogenomics of NQO2: The Past and the Future 16
null 2
Totale 2.655
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.847
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 6 6 7 8 11 1 0
2021/2022128 2 0 0 22 5 2 10 22 30 17 13 5
2022/2023376 54 28 29 10 42 30 5 28 40 42 47 21
2023/2024469 87 34 42 37 41 70 27 38 10 17 32 34
2024/2025843 74 20 28 42 51 109 51 53 51 22 149 193
2025/2026744 102 147 128 164 148 55 0 0 0 0 0 0
Totale 2.655